It's been almost three years since Toyota launched its first-ever mainstream battery-electric vehicle here in North America.

American consumers were snapping up Toyota Motor’s hybrids, and a weak yen inflated the value of the company’s earnings. That May, Toyota reported the highest annual profit ever recorded by a ...

TOKYO, April 27 (Reuters) - Toyota Motor (7203.T), opens new tab said it is exploring the possibility of investing in a potential buyout of key parts supplier Toyota Industries (6201.T), opens new ...

Toyota unveiled the bZ7, a new flagship electric sedan based on the synonymous concept intended for China. The automaker leveraged its partnership with the Chinese firm GAC to develop the sedan ...

GENEVA, March 26, 2025--(BUSINESS WIRE)--Regulatory News: Alcon (SIX/NYSE: ALC), the global leader in eye care dedicated to helping people see brilliantly, today announced it has acquired a ...

Aurion Resources (TSXV: AU) is teaming up with KoBold Metals, the mineral exploration company backed by Jeff Bezos and Bill Gates, to unlock the critical minerals potential of its Risti project in ...

Joint venture: Following satisfaction by KoBold of the earn-in requirements, a joint venture will be established with KoBold owning 75% and Aurion 25%. Net smelter returns royalty: In case an ...

Toyota said three new EVs will launch for the European market by 2026, showing off silhouettes of the cars in a teaser image. One of the SUVs looks like the 2023 Land Cruiser Se concept, while the ...

The Celica was last produced in 2006, leaving a void in Toyota’s lineup for a lightweight, enthusiast-focused coupe. However, rumors of its revival have circulated for years, and in November ...

A redesigned sixth-generation Toyota RAV4 is anticipated to debut in 2025 The new RAV4 may be offered exclusively with hybrid powertrains The starting price should continue to remain in the low $ ...

A judge has ruled against investor Alcon Research on the matter of blocking investee Aurion Biotech from debuting on the public market, a decision Alcon says it will move to appeal. Cell therapy ...

Cell therapy company Aurion Biotech is moving forward with plans to IPO despite a pending lawsuit from one of its existing investors. The eye-disease-focused company plans to list on the New York ...